Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3267

5 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3267 09 S132)

Pdp (68071 3267 09 S132)
Label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 90 tablets. It includes NDC 68071-3267 and product number R1522090. The label states Rx only and includes storage instructions to keep at 68-77°F and warnings to keep out of reach of children.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing the cumulative incidence percentage over time in years for Atorvastatin compared to placebo. The solid line represents Atorvastatin, and the dashed line represents placebo, tracking incidence rates up to 3.5 years. Statistical results including hazard ratio and p-value are annotated below the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A cumulative hazard graph comparing placebo and atorvastatin over a period of up to 5 years, measuring time to first primary endpoint. The graph shows two distinct lines representing placebo (dashed) and atorvastatin (solid), with the atorvastatin line consistently lower than placebo, indicating lower cumulative hazard.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing an event over time between Atorvastatin 10 mg (dotted line) and Atorvastatin 80 mg (solid line). The x-axis represents time in years up to 5 years to first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event, ranging from 0 to 0.2. A hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002 are noted on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium as shown in the image, depicting the molecular arrangement of the active ingredient in this prescription drug tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.